Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

Biomarker could improve prediction of response to immunotherapy in black skin cancer

Biomarker could improve prediction of response to immunotherapy in black skin cancer

Researchers develop a nanoparticle that can penetrate the blood-brain barrier

Researchers develop a nanoparticle that can penetrate the blood-brain barrier

Team facilitates personalised treatment opportunities for malignant brain tumour, glioblastoma

Team facilitates personalised treatment opportunities for malignant brain tumour, glioblastoma

Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer

Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced...

Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery

Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with...

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive...

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

IAEA strengthens cooperation in cancer care at Europe and Central Asia’s first anchor centre in Türkiye

IAEA strengthens cooperation in cancer care at Europe and Central Asia’s first anchor centre in Türkiye

Researchers identify biomarkers in blood to predict liver cancer

Researchers identify biomarkers in blood to predict liver cancer

Promising personalised approach to liver cancer therapy made possible by DNA-based neoantigen research

Promising personalised approach to liver cancer therapy made possible by DNA-based neoantigen research

More from ecancer